Back
Vertex Pharmaceuticals Stock Price Chart
Sponsored
VRTX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
VRTX
Vertex Pharmaceuticals
Last Price:
450.38
Seasonality Move:
11.1%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Vertex Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 475.28 | Sell |
20-day SMA: | 480.34 | Sell |
50-day SMA: | 474.92 | Sell |
200-day SMA: | 453.64 | Sell |
8-day EMA: | 469.24 | Sell |
20-day EMA: | 476.78 | Sell |
50-day EMA: | 476.74 | Sell |
200-day EMA: | 452.69 | Sell |
Vertex Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.34 | Sell |
Relative Strength Index (14 RSI): | 38.05 | Sell |
Chaikin Money Flow: | 1367870 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (464.53 - 495.47) | Sell |
Bollinger Bands (100): | (465.6 - 492.12) | Sell |
Vertex Pharmaceuticals Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 451.23 while VRTX 8-day simple moving average is 475.28, which is a Sell signal.
- The stock price of VRTX is 451.23 while Vertex Pharmaceuticals 20-day SMA is 480.34, which makes it a Sell.
- Vertex Pharmaceuticals 50-day simple moving average is 474.92 while VRTX share price is 451.23, making it a Sell technically.
- VRTX stock price is 451.23 and Vertex Pharmaceuticals 200-day simple moving average is 453.64, creating a Sell signal.
VRTX Technical Analysis vs Fundamental Analysis
Sell
46
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Sell
The current Vertex Pharmaceuticals [VRTX] share price is $451.23. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
116.2B
Price in USD:
451.23
Share Volume:
1.64M
Vertex Pharmaceuticals 52-Week Range
52-Week High:
519.88
52-Week Low:
346.29
Sell
46
Vertex Pharmaceuticals (VRTX)
is a Sell
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?
The Vertex Pharmaceuticals stock price is 451.23 USD today. -
Will VRTX stock go up or go down?
Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Vertex Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 451.23 while VRTX 8-day exponential moving average is 469.24, which is a Sell signal.
- The stock price of VRTX is 451.23 while Vertex Pharmaceuticals 20-day EMA is 476.78, which makes it a Sell.
- Vertex Pharmaceuticals 50-day exponential moving average is 476.74 while VRTX share price is 451.23, making it a Sell technically.
- VRTX stock price is 451.23 and Vertex Pharmaceuticals 200-day simple moving average is 452.69, creating a Sell signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.37 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
- VRTX Moving Average Covergence Divergence (MACD) indicator is -3.34, suggesting Vertex Pharmaceuticals is a Sell
- Vertex Pharmaceuticals Relative Strength Index (RSI) is 38.05, which suggest Vertex Pharmaceuticals is oversold
- The Bollinger Bands (25) for Vertex Pharmaceuticals is (464.53 - 495.47), which suggest Vertex Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Vertex Pharmaceuticals is (465.6 - 492.12), which suggest Vertex Pharmaceuticals is a Sell
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.